HIV‐1 Protease‐Inhibitoren im Überblick
- 1 January 1998
- journal article
- research article
- Published by Wiley in Pharmazie in unserer Zeit
- Vol. 27 (1) , 22-25
- https://doi.org/10.1002/pauz.19980270107
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Current Knowledge and Future Prospects for the Use of HIV Protease InhibitorsDrugs, 1996
- Improved cyclic urea inhibitors of the HIV-1 protease: synthesis, potency, resistance profile, human pharmacokinetics and X-ray crystal structure of DMP 450Chemistry & Biology, 1996
- Structure-Based Design of Novel HIV Protease Inhibitors: Sulfonamide-Containing 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Potent Non-Peptidic InhibitorsJournal of Medicinal Chemistry, 1996
- Rational Design of Potent, Bioavailable, Nonpeptide Cyclic Ureas as HIV Protease InhibitorsScience, 1994
- Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 proteaseAntimicrobial Agents and Chemotherapy, 1991
- Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A.Proceedings of the National Academy of Sciences, 1988